!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Weather Update

Baylor College of Medicine will be open Wednesday and Baylor Medicine will be seeing patients. Please prioritize your safety and take appropriate safety precautions if driving in any high water. View message. 

Baylor College of Medicine

Early Recognition of Genetic Epilepsy in Neonates (H-34852)

Description

Content

Early Recognition of Genetic Epilepsy in Neonates (ERGENT)

Newborn babies with seizures requiring drug treatment, and for whom routine blood and imaging tests fail to reveal an underlying cause, may qualify for free-of-charge genetic panel testing through enrollment in this study. Patients must have seizure onset by 42 weeks gestational age. A medical caregiver (M.D. or R.N.) must apply for eligibility screening via a very brief online form at www.ergent.org. For questions, please see the website and/or contact us at ergent-info@bcm.edu.

More about this study

Contact

Dr. Edward Cooper

Phone 1: 713–798–4939

IRB: H-34852

Status:

Active

Created:

Back to topback-to-top